Pancreatic ductal adenocarcinoma (PDAC) is normally a lethal disease in immediate need to have of newer therapeutic modalities. for PDAC treatment. PDAC cell range. We also discovered that the ERK-selective inhibitor SCH772984 enhances the antitumor activity of VS-5584 leading to significant improvement of cell loss of life and significant inhibition of cell migration inside a… Continue reading Pancreatic ductal adenocarcinoma (PDAC) is normally a lethal disease in immediate